by in
Entry Author Date Location
Amylin & Takeda Halt Obesity Drug Development 08/04/11 San Diego
GI Dynamics and Exa File for IPOs in Weight Loss Devices, Automotive Software 08/04/11 Boston
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Bydureon Sent Back to FDA 07/28/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News 07/28/11 San Diego
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA 07/07/11 San Diego
Optivia Biotech Finds its Way to Profits, With a Little Help from Friends at the FDA 07/05/11 San Francisco
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News 06/30/11 San Diego
Bristol Churns Out Diabetes Data 06/27/11 New York
The Auto Magnate and the Scientist: How Mass General is Working With Lee Iacocca to Find a Diabetes Cure 06/24/11 Boston
A San Diego Sampler from the War on Diabetes 06/24/11 San Diego
Link Between Cardiovascular And Metabolic Diseases? That’s What Esperion Therapeutics Founder Has Been Trying To Tell You 06/23/11 Detroit
Amylin, Alkermes Diabetes Med OKd in EU 06/21/11 San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News 06/09/11 San Diego
Amylin Gets TRO Against Lilly 05/26/11 San Diego
Shire Buys Advanced BioHealing for $750 Million 05/17/11 New York
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug 05/16/11 San Diego
Halozyme Deal Could Yield $83M, Wireless Health Leaders Converge, Readers Vote on Worst Drug Names, & More San Diego Life Sciences News 05/12/11 San Diego
Kilimanjaro Energy Seeks to Pop Loose Trillions’ Worth of Underground Oil, Save the World 05/02/11 San Francisco
CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication 04/18/11 San Diego
Biotech’s Missed Opportunity: Small-Town and Rural America 04/18/11 National
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug 04/15/11 San Diego
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News 04/15/11 San Francisco
Calibra Medical, Maker of Cheap Mechanical Insulin Pump, Pockets $8.1 M 04/14/11 San Francisco
Columbia Teams With Sanofi on Diabetes Research 03/28/11 New York
Tethys Snags U.S. Air Force Support for Big Diabetes Prevention Study 03/23/11 San Francisco
Amylin and Takeda Suspend Obesity Study to Consider Metreleptin Data 03/16/11 San Diego
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News 03/11/11 San Francisco
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
Tethys Seeks to Double Sales of Test, Prove Value of Preventing Diabetes 03/08/11 San Francisco
Page 4 of 11 « previous page · next page »